MiR-132 increases proliferation and decreases apoptosis in pancreatic cancer cells by cyclin-D1 downregulation and acting on other important cellular mediators such as caspase-3 or -9 (174). The gene discussed is CCND1; the disease is pancreatic neoplasm.